Roviello F, Marrelli D, de Manzoni G, Morgagni P, Di Leo A, Saragoni L, De Stefano A
Unit of Surgical Oncology, University of Siena, Via da Gasperi 5, 53100 Siena, Italy.
Br J Surg. 2003 Sep;90(9):1113-9. doi: 10.1002/bjs.4164.
Peritoneal carcinomatosis is a common cause of failure after surgery for gastric cancer. The present longitudinal study was designed to evaluate the incidence and potential predictors of peritoneal recurrence after curative resection for gastric cancer.
Four hundred and forty-one patients who underwent potentially curative resections for gastric cancer in three surgical centres between 1988 and 1996 were evaluated. All patients were followed using a standard protocol following discharge from hospital. The correlation between tumour recurrence and clinicopathological variables was studied by univariate and multivariate analyses.
Gastric cancer recurred in 215 (49 per cent) of 441 patients. Peritoneal recurrence was observed in 77 patients (17 per cent), locoregional recurrence in 96 patients and haematogenous recurrence in 75. Multivariate logistic regression analysis of factors associated with peritoneal recurrence identified diffuse-mixed histological type (relative risk (RR) 4.31, P < 0.001), infiltration of the serosa (RR 3.36, P = 0.001), lymph node involvement (RR 2.67, P = 0.023) and tumour size (RR 1.11, P = 0.050) as significant independent variables. In the diffuse-mixed histological subtype, the 5-year cumulative risk of peritoneal recurrence was 12 per cent in the absence of serosal invasion, and 69 per cent in patients with infiltration of the serosa; in the intestinal subtype, the cumulative risk in patients with serosa-negative and -positive tumours was 4 and 21 per cent respectively.
Radical surgery offers a low probability of cure in patients with diffuse-mixed type of gastric cancer and involvement of the serosa, due to a high risk of peritoneal recurrence. These patients might benefit from adjuvant therapies to prevent peritoneal carcinomatosis.
腹膜癌转移是胃癌手术后治疗失败的常见原因。本纵向研究旨在评估胃癌根治性切除术后腹膜复发的发生率及潜在预测因素。
对1988年至1996年间在三个外科中心接受胃癌潜在根治性切除术的441例患者进行评估。所有患者出院后均按照标准方案进行随访。通过单因素和多因素分析研究肿瘤复发与临床病理变量之间的相关性。
441例患者中有215例(49%)出现胃癌复发。观察到77例(17%)发生腹膜复发,96例发生局部区域复发,75例发生血行转移复发。对与腹膜复发相关因素的多因素逻辑回归分析确定,弥漫-混合型组织学类型(相对风险(RR)4.31,P<0.001)、浆膜浸润(RR 3.36,P = 0.001)、淋巴结受累(RR 2.67,P = 0.023)和肿瘤大小(RR 1.11,P = 0.050)为显著独立变量。在弥漫-混合型组织学亚型中,无浆膜侵犯患者的5年腹膜复发累积风险为12%,浆膜浸润患者为69%;在肠型亚型中,浆膜阴性和阳性肿瘤患者的累积风险分别为4%和21%。
由于腹膜复发风险高,根治性手术对弥漫-混合型胃癌且有浆膜受累的患者治愈可能性低。这些患者可能从辅助治疗中获益以预防腹膜癌转移。